ArticleThe breast journal2023

MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study.

Minghe LvPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.